Holen Sie sich die Stockscreener-App
1.26
2.33%
-0.03
Handel nachbörslich:
1.25
-0.01
-0.79%
Schlusskurs vom Vortag:
$1.29
Offen:
$1.29
24-Stunden-Volumen:
514.95K
Relative Volume:
3.57
Marktkapitalisierung:
$52.78M
Einnahmen:
$9.16M
Nettoeinkommen (Verlust:
$-68.17M
KGV:
-0.773
EPS:
-1.63
Netto-Cashflow:
$-80.16M
1W Leistung:
-9.35%
1M Leistung:
-7.35%
6M Leistung:
-16.00%
1J Leistung:
-25.88%
1-Tages-Spanne:
$1.26
$1.295
1-Wochen-Bereich:
$1.26
$1.47
52-Wochen-Spanne:
$0.9707
$1.94
Ikena Oncology Inc Stock (IKNA) Company Profile
Firmenname
Ikena Oncology Inc
Sektor
Branche
Telefon
857-343-8292
Adresse
50 NORTHERN AVE., BOSTON
Vergleichen Sie IKNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IKNA
Ikena Oncology Inc
|
1.26 | 67.08M | 9.16M | -68.17M | -80.16M | -1.63 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.27 | 123.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.00 | 60.43B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.69 | 42.07B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
572.71 | 34.47B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
290.35 | 27.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Ikena Oncology Inc Stock (IKNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-29 | Herabstufung | Wedbush | Outperform → Neutral |
| 2023-09-22 | Eingeleitet | Wedbush | Outperform |
| 2023-05-04 | Fortgesetzt | H.C. Wainwright | Buy |
| 2021-12-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-05-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-20 | Eingeleitet | Credit Suisse | Outperform |
| 2021-04-20 | Eingeleitet | Jefferies | Buy |
| 2021-04-20 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Ikena Oncology Inc Aktie (IKNA) Neueste Nachrichten
Ikena Oncology amends executive agreement with Dr. Jotin Marango for equity vesting By Investing.com - Investing.com South Africa
Ikena Oncology amends executive agreement with Dr. Jotin Marango for equity vesting - Investing.com
Ikena Oncology Updates Employment Terms Amid Merger Plans - TipRanks
Ikena Oncology Announces Stockholder Approval of Merger with Inmagene Biopharmaceuticals - GlobeNewswire
How Ikena Oncology Inc. stock performs during market volatilityIntraday Trade Ideas - Newser
Ikena Oncology Approves Merger and Reverse Stock Split - TipRanks
Ikena Oncology announces stockholder approval of merger with Inmagene Biopharmaceuticals - MarketScreener
Ikena announces 1-for-12 reverse stock split, approval of Inmagene merger - TipRanks
Ikena shareholders approve merger with Inmagene, reverse stock split By Investing.com - Investing.com South Africa
Ikena Oncology Approves Merger with Inmagene Biopharmaceuticals - AInvest
Ikena Oncology Shareholders Green Light Inmagene Merger: What the 1-for-12 Split Means for Investors - Stock Titan
Why Ikena Oncology Inc. stock attracts strong analyst attentionFree Best Performing Stock Alerts - Newser
What makes Ikena Oncology Inc. stock price move sharplySafe High Return Entry Points - Newser
SBET spends $25.7M on 10,000 ETH; Share-reserve waiver opens ATM issuances | IKNA SEC FilingForm 8-K - Stock Titan
Ikena Oncology Announces Support from ISS and Glass Lewis for Shareholder Vote on Inmagene Merger - Nasdaq
Ikena Oncology Announces ISS and Glass Lewis Recommend - GlobeNewswire
Ikena Oncology (NASDAQ:IKNA) Stock Price Up 1.5% – Here’s Why - Defense World
Ikena Oncology: Inmagene Begins Phase 2b Study for IMG-007 - TipRanks
Two Sigma Investments LP Sells 55,935 Shares of Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Squarepoint Ops LLC Acquires Shares of 43,640 Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Millennium Management LLC Trims Stake in Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Citadel Advisors LLC Lowers Position in Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Two Sigma Advisers LP Has $258,000 Stock Holdings in Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Ikena Oncology, Inc. (NASDAQ:IKNA) Shares Bought by Northern Trust Corp - Defense World
BNP Paribas Financial Markets Acquires New Position in Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Ikena Oncology Reports Q1 Loss Amid Merger Plans - TipRanks
Ikena Oncology Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Ikena Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Ikena Oncology, Inc. SEC 10-Q Report - TradingView
Renaissance Technologies LLC Sells 70,400 Shares of Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Geode Capital Management LLC Purchases 56,936 Shares of Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Marquis Who's Who Honors Wilmin P. Bartolini for Expertise in Pharmaceutical Consulting - 24-7 Press Release Newswire
Prudential Financial Inc. Trims Holdings in Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Ikena Oncology stock hits 52-week low at $0.98 amid market challenges - Investing.com Canada
Ikena Oncology stock hits 52-week low at $0.98 amid market challenges By Investing.com - Investing.com South Africa
Ikena Oncology stock hits 52-week low at $1.21 amid market challenges - Investing.com Australia
Ikena Oncology stock hits 52-week low at $1.21 amid market challenges By Investing.com - Investing.com South Africa
Ikena Oncology Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares - Business Wire
Ikena Oncology: Investor Caution as Dividend Payments Remain Unlikely - TipRanks
Ikena Oncology Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Ikena Oncology Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
Ikena Oncology, Inc. SEC 10-K Report - TradingView
Short Interest in Ikena Oncology, Inc. (NASDAQ:IKNA) Decreases By 11.8% - MarketBeat
Discovering February 2025's Promising Penny Stocks On US Exchanges - Simply Wall St
Ikena Oncology (NASDAQ:IKNA) Stock Price Down 0.7%Here's Why - MarketBeat
A History of Outperforming Analyst Forecasts and Beating the Odds: Ikena Oncology Inc (IKNA) - SETE News
Understanding the Risks of Investing in Ikena Oncology Inc (IKNA) - Knox Daily
Ikena Oncology Merger with Inmagene Biopharmaceuticals and Private Placement Financing - Leerink Partners
Jane Street Group LLC Sells 18,570 Shares of Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Finanzdaten der Ikena Oncology Inc-Aktie (IKNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):